Compositions Containing Nucleosides and Manganese and Their Uses
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/US2008/073479, filed Aug 18, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,342,871 | Compositions Containing Nucleosides and Manganese and Their Uses In force · High confidence UsedRemaining | The Government of the USA, as Represented by the Secretary, Department of Health and Human Services | In force | High confidence | ||
| US 9,186,406 | Compositions Containing Nucleosides and Manganese and Their Uses In force · High confidence | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | In force | High confidence | ||
| US 9,758,760 | Compositions Containing Amino Acids, Phosphate and Manganese and Their Uses In force · High confidence | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | In force | High confidence | ||
| US 9,234,168 | Compositions Containing Amino Acids, Phosphate and Manganese and Their Uses In force · High confidence | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | In force | High confidence | ||
| Application 16/504,941 | Compositions Containing Nucleosides and Manganese and Their Uses Abandoned Abandoned Feb 28, 2022 | The Government of the USA as Represented by the Secretary Department of Health and Human Services | Abandoned | Abandoned Feb 28, 2022 | ||
| Application 14/355,063 | Compositions Containing Purine and Pyrimidine Nucleosides, Peptides, and Manganese and Their Uses Abandoned Abandoned Aug 11, 2015 | National Institutes of Health | Abandoned | Abandoned Aug 11, 2015 |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Henry Company LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.